MRI-Enhanced Screening Strategy Noninferior for Prostate Cancer ​

MONDAY, July 12, 2021 -- Magnetic resonance imaging (MRI) with targeted and standard biopsy for men with MRI results indicative of prostate cancer is noninferior to standard biopsy for identifying clinically significant prostate cancer, according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news